Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Press Releases
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société BAYER AG
10/18BAYER : Belmora Seeks SCOTUS Review For The Second Time In Its Cross-Border Trademark Batt..
AQ
10/01BAYER : Gadovist™ (Gadobutrol) at a Reduced Dose Demonstrates Non-Inferiority Compar..
PU
09/27BAYER : New data for rivaroxaban in patients following the Fontan procedure and at risk fo..
PU
09/26BAYER : Middle East announces partnership with the United Nations Population Fund Egypt, t..
PU
09/20BAYER : extends clinical development program for finerenone with Phase III study in patien..
PU
09/20BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
09/16BAYER : launches transparency register for scientific collaborations with external partner..
PU
09/16BAYER : Latest analyses of Vitrakvi (larotrectinib) reaffirm powerful efficacy and tolerab..
PU
09/14BAYER : Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Caval..
BU
09/09BAYER : to highlight expanded research from growing oncology portfolio at ESMO Congress 20..
PU
09/08BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
09/06BAYER : Eliapixant significantly decreased cough frequency in Phase IIb trial in patients ..
PU
08/31BAYER : starts Phase III clinical development program OASIS with Elinzanetant
PU
08/30BAYER : New Data on Finerenone for the protection of patients with chronic kidney disease ..
AQ
08/28BAYER : New Data on Finerenone for the protection of patients with chronic kidney disease ..
PU
08/24BAYER : U.S. FDA approves expansion of the peripheral artery disease (PAD) indication for ..
PU
08/19BAYER : to present data from cardiovascular portfolio, including late breaking data from P..
PU
08/17BAYER : to present data from cardiovascular portfolio, including late breaking data from P..
PU
08/12BAYER : Belmora Files Petition For Writ Of Cetiorari In Long-Running FLANAX Battle With Ba..
AQ
08/05BAYER : strengthens-drug-discovery-platform-through-acquisition-of-Vividion-Therapeutics
AQ
08/05BAYER : Half-Year Financial Report 2021 English (PDF, 582 KB)
PU
08/05BAYER : Strong growth, guidance upgrade
PU
08/05BAYER : strengthens drug discovery platform through acquisition of Vividion Therapeutics
PU
08/04BAYER : investigational P2X3 antagonist meets primary efficacy endpoint and shows favorabl..
AQ
08/03BAYER : selects 100 youth leaders from around the world to help 'Feed a Hungry Planet' at ..
AQ
08/03BAYER : investigational P2X3 antagonist meets primary efficacy endpoint and shows favorabl..
PU
07/28BAYER : Monsanto told to pay teachers $185M over chemical exposure
AQ
07/21BAYER : new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approv..
PU
07/08BAYER : Umana Medical announces collaboration with the University Medical Center Mainz and..
AQ
06/29BAYER : launches its decarbonization program for agriculture in Europe
PU
06/24BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
06/23BAYER : Rivaroxaban application submitted to U.S. FDA for approval to treat VTE and to pre..
PU
06/23BAYER : Vericiguat approved in Japan to treat patients with chronic heart failure
PU
06/21BAYER : submits regulatory applications for oncology treatment combination of copanlisib a..
PU
06/14BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
06/10BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
06/09BAYER : BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase 1 Study in ..
AQ
06/09BAYER : to advance two first-of-its-kind cell and gene therapies for Parkinson's disease
AQ
06/08BAYER : to advance two first-of-its-kind cell and gene therapies for Parkinson's disease
PU
06/07BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
06/07BAYER : Fourth Circuit Holds That Equitable Defense Of Laches, Not Most Analogous Statute ..
AQ
06/03BAYER : acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer
PU
06/02BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
05/28BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
EQ
05/26BAYER AKTIENGESELLSCHAFT : Bayer announces five-point plan to effectively address potentia..
EQ
05/26BAYER CROPSCIENCE LIMITED : reports Q4 & Annual Results
AQ
05/26BAYER : AskBio Announces IND for LION-101, a Novel Investigational AAV Gene Therapy for th..
AQ
05/25BAYER : Precision oncology treatment Larotrectinib submitted for marketing authorization i..
PU
05/21BAYER : Positive CHMP opinion for Bayer's new symptomatic chronic heart failure treatment ..
PU
05/19BAYER : BMO Farm to Market Conference
PU
05/18BAYER : Finerenone has potential to reduce the risk of new onset atrial fibrillation or fl..
AQ
05/18BAYER : brings 'Feeding a Hungry Planet' into focus by inviting young leaders around the g..
AQ
05/18BAYER : Berenberg US Conference
PU
05/17BAYER : Finerenone has potential to reduce the risk of new onset atrial fibrillation or fl..
PU
05/14BAYER : Appeals court upholds $25M award in Monsanto cancer case
AQ
05/12BAYER : Quarterly Statement First Quarter 2021 English (PDF, 399 KB)
PU
05/12BAYER : successful start to 2021
PU
05/11BAYER : presents expanded research and new approaches to advance cancer care at 2021 ASCO ..
PU
05/10BAYER : announces two late-breaking presentations which include data from FIDELIO-DKD (fin..
PU
05/10BAYER : finerenone meets primary endpoint in Phase III FIGARO-DKD cardiovascular outcomes ..
PU
05/10JOHNS HOPKINS UNIVERSITY : Bayer extends research agreement with Hopkins through 2024; The..
AQ
05/07BAYER : Climate FieldView, CLAAS TELEMATICS offer easy data management to help simplify fa..
AQ
05/06BAYER : Climate FieldView™, CLAAS TELEMATICS offer easy data management to help simp..
PU
05/05BAYER AKTIENGESELLSCHAFT : Preliminary announcement of the publication of financial report..
EQ
05/05BAYER : Collaboration with Alexander von Humboldt Foundation expanded
PU
04/27BAYER : “We're optimistic for the future”
PU
04/27BAYER : Annual Stockholders' Meeting 2021
PU
04/14BAYER : and SVG Ventures | THRIVE partner to tackle agriculture's grand challenge
PU
04/10BAYER : Combination of copanlisib and rituximab significantly increases progression-free s..
PU
04/06BAYER : to present new clinical data in indolent non-Hodgkin's Lymphoma and additional res..
PU
04/01BAYER : Industry leading digital farming platform Climate FieldView launches in South Afri..
AQ
03/25BAYER : E.D. Arkansas Dismisses Essure Claims
AQ
03/22BAYER : receives approval for Vitrakvi™ in Japan
PU
03/18BAYER : Federal Circuit Confirms That A Patent Damages Expert May Opine On A Range Of Roya..
AQ
03/12BAYER : to further strengthen expertise and international profile of its Supervisory Board
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on BAYER AG